MELLO develops probiotic delivery technology to enhance the effective delivery of probiotics.
MELLO's investors include BioInnovation Institute, BioInnovation Institute Venture House.
MELLO is headquartered in Copenhagen, Denmark.
MELLO develops probiotic delivery technology to enhance the effective delivery of probiotics.
MELLO is at the Convertible Note stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"MELLO — Funding & Investors." VCBacked, March 16, 2023, https://www.vcbacked.co/company/mello. Accessed November 11, 2026.
VCBacked. (2023). MELLO — Funding & Investors. Retrieved November 11, 2026, from https://www.vcbacked.co/company/mello
{{cite web |title=MELLO — Funding & Investors |url=https://www.vcbacked.co/company/mello |website=VCBacked |access-date=November 11, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated
Work at MELLO? Request a listing update